<DOC>
	<DOCNO>NCT00874068</DOCNO>
	<brief_summary>The purpose study determine effect high sn-2 palmitic acid base infant formula bone strength parameter .</brief_summary>
	<brief_title>The Effects Dietary Palmitic Acid Triacylglyceride Position Bone Strength Parameters Infants</brief_title>
	<detailed_description>InFatTM advance basic-fat ingredient , mimic fat composition property human milk fat enable optimal intake essential calcium energy ( form fatty acid ) easy digestion . These benefit result unique fatty acid composition glycerol backbone , ensure high level palmitic acid middle ( sn-2 ) position . The purpose study determine effect high sn-2 palmitic acid base infant formula bone strength parameter , anthropometric parameter , wellbeing stool characteristic term preterm infant .</detailed_description>
	<mesh_term>Palmitic Acid</mesh_term>
	<criteria>1 . Gestational age 32 week determine menstrual history corroborate prenatal US and/or physical examination . 2 . Birth weight appropriate gestational age ( AGA ) use current CDC growth chart , 1750gr . 3 . The mother unequivocally decide breastfeed ( formula group ) mother decide breast feed ( human breast milk group ) . 4 . The infant apparently healthy . 5 . Parental/ legal guardian write inform consent 6 . Apgar 5 minute &gt; 7 7 . Enrolled within first 14 day life term infant first month life preterm infant 8 . At enrollment : clinical stability acceptable weight gain 1 . The infant suffer congenital chromosomal disorder ( Cystic fibrosis , Tracheomalacia , Tracheoesophageal fistula , major congenital heart disease , downsyndrome ) 2 . The infant suffer neonatal morbidity : Bronchopulmonary dysplasia ( BPD ) Intraventricular Hemorrhage34 ( IVH ) Necrotizing Enterocolitis ( NEC ) 3 . Laboratory clinical sings Osteopenia 4 . The infant suffers suspect know metabolic physical limitation interfere feed normal metabolism ( require special formula ) 5 . The mother suffers disease disability may interfere ability take care infant 6 . Any reason , opinion investigator , prevents subject participate study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Month</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>term infant</keyword>
	<keyword>preterm infant</keyword>
	<keyword>bone strength</keyword>
	<keyword>Speed sound ( SOS )</keyword>
	<keyword>Ultrasound</keyword>
</DOC>